Disease_category,Disease,Protein,Protein_definition,Method,Nb_SNP,OR[95%CI],P_value
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6,Interleukin-6,Inverse variance weighted,6,0.92 [0.83-1.03],0.161253696315309
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,12,1.06 [0.98-1.15],0.138999207335283
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,1.05 [0.81-1.35],0.732858156566383
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA14,Carbonic anhydrase 14,Inverse variance weighted,21,0.97 [0.88-1.06],0.486549747084158
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,13,1.06 [0.95-1.18],0.326954248273272
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGMN,Legumain,Inverse variance weighted,32,0.98 [0.91-1.05],0.568456762158368
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL19,Interleukin-19,Inverse variance weighted,21,1.01 [0.95-1.09],0.667662722362662
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,1.01 [0.97-1.05],0.685912321858436
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,1.09 [0.90-1.31],0.365603622135555
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP7,Dipeptidyl peptidase 2,Inverse variance weighted,15,0.99 [0.95-1.04],0.679324053144189
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA4,Ephrin-A4,Inverse variance weighted,5,0.83 [0.69-1.00],0.0455565570254063
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,8,1.03 [0.94-1.13],0.479809479635161
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBS2,Thrombospondin-2,Inverse variance weighted,33,0.98 [0.94-1.03],0.379435923032172
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BPIFB1,BPI fold-containing family B member 1,Inverse variance weighted,58,1.07 [1.02-1.11],0.0017571247580669
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASET2,Ribonuclease T2,Inverse variance weighted,25,1.04 [0.99-1.08],0.124553812016697
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,14,0.96 [0.87-1.06],0.39595511722996
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA5,Integrin alpha-5,Inverse variance weighted,19,1.02 [0.93-1.12],0.653984542695405
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS4,Galectin-4,Inverse variance weighted,19,0.99 [0.95-1.04],0.808100904773823
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COLEC12,Collectin-12,Inverse variance weighted,13,1.09 [0.97-1.24],0.153677561400634
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,42,1.04 [0.98-1.11],0.199495153002253
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,15,1.00 [0.93-1.07],0.965785270010224
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,Inverse variance weighted,35,0.99 [0.95-1.04],0.787251251692386
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRLB,Fc receptor-like B,Inverse variance weighted,65,1.00 [0.98-1.03],0.750405709914357
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,Inverse variance weighted,24,0.96 [0.91-1.02],0.172153890302614
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,32,0.98 [0.94-1.02],0.25420636402791
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REN,Renin,Inverse variance weighted,12,0.99 [0.90-1.10],0.895255586577899
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCLY,Selenocysteine lyase,Inverse variance weighted,7,1.04 [0.94-1.14],0.453708986460119
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,1.12 [0.89-1.40],0.342344696387601
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,18,0.95 [0.85-1.06],0.38100906351649
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSAP,Prosaposin,Inverse variance weighted,13,1.02 [0.96-1.10],0.506395318977731
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,0.97 [0.86-1.10],0.655708579507554
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FBP1,"Fructose-1,6-bisphosphatase 1",Inverse variance weighted,11,1.00 [0.93-1.07],0.948915896490559
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKB,Creatine kinase B-type,Inverse variance weighted,11,0.93 [0.77-1.12],0.460518455752716
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF2,Trefoil factor 2,Inverse variance weighted,16,0.96 [0.88-1.05],0.361225800772503
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,11,1.06 [0.98-1.15],0.1435498218713
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD163,Scavenger receptor cysteine-rich type 1 protein M130,Inverse variance weighted,38,1.06 [0.97-1.16],0.186870758092076
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGA4,Pepsin A-4,Inverse variance weighted,9,1.12 [0.98-1.29],0.0985135588365072
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLGN,Calmegin,Inverse variance weighted,22,1.00 [0.97-1.04],0.850611288963737
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD27,CD27 antigen,Inverse variance weighted,18,0.96 [0.90-1.03],0.247736486802726
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.09 [1.02-1.17],0.0121410278936293
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,16,0.95 [0.90-1.01],0.12848625792224
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN2,Nectin-2,Inverse variance weighted,8,0.96 [0.91-1.02],0.198403145147361
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDAR,Tumor necrosis factor receptor superfamily member EDAR,Inverse variance weighted,50,0.99 [0.96-1.03],0.715580169558614
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CREG1,Protein CREG1,Inverse variance weighted,24,1.00 [0.97-1.04],0.901117894680367
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,12,0.93 [0.83-1.03],0.143839608685624
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELENOP,Selenoprotein P,Inverse variance weighted,5,1.04 [0.82-1.31],0.74714888926931
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE6,Ribonuclease K6,Inverse variance weighted,20,1.02 [0.97-1.08],0.499216407493214
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,20,1.08 [1.02-1.15],0.014035813969478
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18,Interleukin-18,Inverse variance weighted,42,1.02 [0.97-1.07],0.359119471971593
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BSG,Basigin,Inverse variance weighted,8,1.21 [1.09-1.36],0.0005933022570486
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,41,0.97 [0.92-1.01],0.157413983323789
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,Inverse variance weighted,33,1.01 [0.97-1.05],0.717006117298683
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,27,1.00 [0.95-1.06],0.889739335973966
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCAR,Immunoglobulin alpha Fc receptor,Inverse variance weighted,36,1.02 [0.98-1.05],0.412826295998886
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,26,1.00 [0.94-1.06],0.897859517893997
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,49,1.01 [0.98-1.05],0.367808495250181
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,10,0.93 [0.84-1.02],0.13151244587466
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Inverse variance weighted,4,0.94 [0.75-1.17],0.562851888461229
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G1B,Phospholipase A2,Inverse variance weighted,21,1.09 [1.01-1.19],0.0306740284782656
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,27,0.99 [0.95-1.03],0.704409595154479
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,21,1.04 [0.97-1.12],0.278960438052194
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFASC,Neurofascin,Inverse variance weighted,19,0.98 [0.93-1.03],0.452609866860506
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLL1,Delta-like protein 1,Inverse variance weighted,13,1.04 [0.93-1.15],0.529249868301845
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGL1,Fibrinogen-like protein 1,Inverse variance weighted,38,0.99 [0.96-1.03],0.776024651376162
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE1,Ribonuclease pancreatic,Inverse variance weighted,6,0.98 [0.88-1.10],0.751666550616108
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,1.14 [1.00-1.30],0.055681751393442
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,10,1.03 [0.97-1.10],0.295015615374642
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,34,1.00 [0.95-1.05],0.903211308955798
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,30,0.99 [0.91-1.07],0.732288560246091
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNC,Tenascin,Inverse variance weighted,57,0.99 [0.96-1.02],0.549952910131045
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MATN2,Matrilin-2,Inverse variance weighted,32,0.99 [0.96-1.03],0.703340210968053
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFA,Protransforming growth factor alpha,Inverse variance weighted,11,1.03 [0.89-1.20],0.650614993905186
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAYN,Layilin,Inverse variance weighted,23,1.04 [0.98-1.11],0.178586314208181
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,23,0.99 [0.90-1.10],0.919050449601685
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,31,0.97 [0.92-1.02],0.276120179112378
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRC1,Macrophage mannose receptor 1,Inverse variance weighted,24,1.07 [0.99-1.17],0.0890207260083171
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,22,1.01 [0.96-1.06],0.65059889529254
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,4,1.03 [0.95-1.12],0.494429783345306
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA11,Serpin A11,Inverse variance weighted,46,0.97 [0.95-1.01],0.106613605625907
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD48,CD48 antigen,Inverse variance weighted,32,0.99 [0.96-1.02],0.629717150714721
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSTN2,Calsyntenin-2,Inverse variance weighted,38,0.98 [0.94-1.02],0.349104065013243
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,19,1.03 [0.99-1.08],0.162084227506192
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17C,Interleukin-17C,Inverse variance weighted,8,1.21 [1.07-1.37],0.0032781816842502
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C7,Complement component C7,Inverse variance weighted,60,1.04 [1.00-1.07],0.0243910909409207
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDCP1,CUB domain-containing protein 1,Inverse variance weighted,23,1.01 [0.96-1.07],0.635525544162004
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ULBP2,UL16-binding protein 2,Inverse variance weighted,37,1.01 [0.98-1.04],0.693911085952532
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BST2,Bone marrow stromal antigen 2,Inverse variance weighted,27,1.00 [0.93-1.08],0.974259117924378
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,25,0.99 [0.93-1.05],0.713406917198584
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN8,Septin-8,Inverse variance weighted,6,1.11 [0.95-1.29],0.192416044234242
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,10,1.04 [0.89-1.20],0.646524606515513
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAU,Urokinase-type plasminogen activator,Inverse variance weighted,27,1.00 [0.94-1.06],0.956128423340318
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCN2,Transcobalamin-2,Inverse variance weighted,66,1.00 [0.98-1.02],0.969171330061822
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD276,CD276 antigen,Inverse variance weighted,47,1.00 [0.97-1.03],0.911367803520681
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,26,0.94 [0.89-0.99],0.0182483704940807
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC1,Sialoadhesin,Inverse variance weighted,31,0.97 [0.92-1.03],0.342929668703307
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,76,0.99 [0.97-1.01],0.187096126598182
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALPP,"Alkaline phosphatase, placental type",Inverse variance weighted,50,0.97 [0.94-1.01],0.113824235740014
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,8,1.05 [0.98-1.11],0.150568365647815
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,18,1.01 [0.95-1.06],0.804192065375934
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON1,Spondin-1,Inverse variance weighted,25,1.01 [0.96-1.06],0.804649699846709
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300E,CMRF35-like molecule 2,Inverse variance weighted,36,1.00 [0.96-1.05],0.863824984711531
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,12,1.02 [0.98-1.07],0.380952398698321
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHISA5,Protein shisa-5,Inverse variance weighted,16,0.90 [0.79-1.02],0.0924921256256053
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUSB,Beta-glucuronidase,Inverse variance weighted,35,1.02 [0.95-1.10],0.56090148187994
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDF15,Growth/differentiation factor 15,Inverse variance weighted,14,1.05 [0.93-1.19],0.416848950798625
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,7,0.96 [0.89-1.04],0.319913252527759
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,5,0.88 [0.73-1.05],0.143559923989264
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,24,1.03 [0.95-1.11],0.478413605468226
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFR,Epidermal growth factor receptor,Inverse variance weighted,15,1.05 [0.93-1.17],0.434227592121144
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,29,1.01 [0.97-1.05],0.647121229917089
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,0.93 [0.86-1.00],0.064422511331647
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,1.00 [0.97-1.04],0.908571445146487
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP4,"Fatty acid-binding protein, adipocyte",Inverse variance weighted,2,0.96 [0.80-1.15],0.67649180291123
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPT2,Angiopoietin-2,Inverse variance weighted,11,1.00 [0.92-1.09],0.969845151607289
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON2,Spondin-2,Inverse variance weighted,8,1.10 [1.00-1.21],0.0455889301999894
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD2,Sushi domain-containing protein 2,Inverse variance weighted,29,1.00 [0.97-1.03],0.899477118994658
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAST,Gastrin,Inverse variance weighted,9,0.95 [0.85-1.07],0.411671563819903
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL3,Follistatin-related protein 3,Inverse variance weighted,7,1.05 [0.88-1.24],0.598822396669287
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,8,0.95 [0.82-1.11],0.509069942680769
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,0.93 [0.80-1.08],0.353538488696975
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP8,Neutrophil collagenase,Inverse variance weighted,25,1.07 [1.02-1.11],0.0015354933116564
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,28,1.00 [0.96-1.04],0.985946852527135
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.06 [0.91-1.24],0.429560943500465
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",Inverse variance weighted,4,1.11 [0.90-1.36],0.33067648707899
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,6,0.96 [0.88-1.05],0.385482744877128
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GM2A,Ganglioside GM2 activator,Inverse variance weighted,26,1.01 [0.98-1.05],0.477080677732679
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP7,Matrilysin,Inverse variance weighted,15,1.01 [0.95-1.06],0.846850506263463
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,0.76 [0.58-0.99],0.0451512195169438
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,19,0.98 [0.92-1.05],0.59043456737427
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,11,1.09 [0.98-1.22],0.105008492679113
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD302,CD302 antigen,Inverse variance weighted,17,0.90 [0.84-0.97],0.0037860829324322
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,16,0.98 [0.92-1.04],0.506115757685411
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,9,0.96 [0.88-1.06],0.468354916361421
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADA2,Adenosine deaminase 2,Inverse variance weighted,18,0.98 [0.88-1.08],0.617456193757405
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC15,Thioredoxin domain-containing protein 15,Inverse variance weighted,47,1.01 [0.98-1.04],0.503889348527915
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA9,Carbonic anhydrase 9,Inverse variance weighted,11,1.00 [0.87-1.14],0.950118057107524
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS22,Brain-specific serine protease 4,Inverse variance weighted,11,1.01 [0.95-1.07],0.807032060686497
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,66,0.99 [0.96-1.02],0.56480729429626
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,32,0.97 [0.92-1.03],0.329503954490032
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,Inverse variance weighted,16,1.00 [0.89-1.12],0.99825600544263
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,11,0.97 [0.83-1.14],0.731491905787584
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,16,0.99 [0.94-1.05],0.796603676728392
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,40,1.00 [0.96-1.05],0.867101708579676
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AREG,Amphiregulin,Inverse variance weighted,7,0.98 [0.88-1.10],0.784551535225689
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAMP5,Vesicle-associated membrane protein 5,Inverse variance weighted,2,0.82 [0.51-1.31],0.400978143941019
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,27,0.98 [0.93-1.04],0.587280700167448
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TTR,Transthyretin,Inverse variance weighted,11,1.09 [0.98-1.21],0.105906020846163
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,9,0.98 [0.87-1.09],0.669048160663708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,Inverse variance weighted,48,1.02 [0.98-1.05],0.353775307106116
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,18,0.93 [0.86-1.02],0.117079452581885
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,0.92 [0.73-1.14],0.442666568421808
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA10,Annexin A10,Wald ratio,1,0.92 [0.62-1.39],0.703044780388155
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",Inverse variance weighted,40,1.05 [1.00-1.11],0.0570380558644238
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MVK,Mevalonate kinase,Inverse variance weighted,3,0.80 [0.62-1.04],0.095538247570238
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC3B,Tetranectin,Inverse variance weighted,9,1.00 [0.90-1.10],0.941371838552915
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEP1B,Meprin A subunit beta,Inverse variance weighted,72,1.02 [0.99-1.04],0.13191115438043
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,16,1.01 [0.95-1.07],0.784691780744128
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,9,0.88 [0.72-1.07],0.207714142628063
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,18,0.99 [0.83-1.18],0.93582880369558
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTN,Pleiotrophin,Inverse variance weighted,7,1.13 [0.92-1.38],0.244770414309437
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,5,0.99 [0.78-1.24],0.914549618573282
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",Inverse variance weighted,25,1.02 [0.97-1.06],0.468918351224719
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,23,1.00 [0.94-1.05],0.894683438441818
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,1.25 [1.06-1.48],0.009496162681451
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RL2,Interleukin-1 receptor-like 2,Inverse variance weighted,53,1.04 [1.00-1.09],0.0352557797875577
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOD2,"Superoxide dismutase [Mn], mitochondrial",Inverse variance weighted,11,0.95 [0.87-1.05],0.302350428915999
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RAP,Interleukin-1 receptor accessory protein,Inverse variance weighted,32,0.99 [0.96-1.01],0.24277181160842
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSD,Cathepsin D,Inverse variance weighted,24,1.00 [0.94-1.05],0.868316517977015
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSM,Oncostatin-M,Inverse variance weighted,7,1.08 [0.92-1.25],0.356596663801328
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP3,Insulin-like growth factor-binding protein 3,Inverse variance weighted,41,1.01 [0.97-1.05],0.739060340518143
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,61,0.98 [0.96-1.01],0.174238102329062
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP12,Macrophage metalloelastase,Inverse variance weighted,21,1.03 [1.00-1.07],0.0352596770325273
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,29,0.97 [0.91-1.03],0.324571945216115
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL22,Interleukin-22,Inverse variance weighted,5,1.18 [0.95-1.46],0.133646507744511
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,20,0.96 [0.91-1.02],0.163487351732648
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB1A1,Uteroglobin,Inverse variance weighted,49,1.03 [0.97-1.09],0.299919068379829
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,24,0.95 [0.91-1.00],0.0483697774776871
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,17,1.03 [0.96-1.10],0.408154991654494
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HGF,Hepatocyte growth factor,Inverse variance weighted,7,0.96 [0.83-1.11],0.57949621914515
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,5,1.06 [0.86-1.31],0.562600077831453
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,6,1.02 [0.86-1.21],0.838049567772743
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,22,1.01 [0.97-1.04],0.763945971906932
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL13,C-X-C motif chemokine 13,Inverse variance weighted,2,0.87 [0.65-1.16],0.337457677860568
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPRC5C,G-protein coupled receptor family C group 5 member C,Inverse variance weighted,7,1.01 [0.87-1.16],0.915608374327882
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,17,1.00 [0.93-1.08],0.950383846434948
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,19,0.93 [0.88-0.97],0.0028152256986639
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK11,Kallikrein-11,Inverse variance weighted,19,1.02 [0.98-1.06],0.325530260098848
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF23,Fibroblast growth factor 23,Inverse variance weighted,17,1.00 [0.92-1.09],0.989961984324509
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,40,1.00 [0.95-1.04],0.847181977751468
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,30,0.97 [0.91-1.04],0.417928111366924
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Inverse variance weighted,2,1.01 [0.71-1.44],0.965217287236078
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNDP1,Beta-Ala-His dipeptidase,Inverse variance weighted,48,1.02 [0.99-1.06],0.19415876971582
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSL3,Insulin-like 3,Inverse variance weighted,3,0.84 [0.57-1.25],0.398642872147773
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF21,Fibroblast growth factor 21,Inverse variance weighted,4,1.08 [0.87-1.34],0.473360327975149
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,18,1.00 [0.95-1.05],0.982329339821111
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,25,0.98 [0.92-1.03],0.396207839492163
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF1,Trefoil factor 1,Inverse variance weighted,14,0.99 [0.93-1.05],0.661196734375116
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHGA,Chromogranin-A,Inverse variance weighted,8,0.96 [0.85-1.08],0.498610568752466
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KITLG,Kit ligand,Inverse variance weighted,31,1.04 [0.97-1.10],0.286137921848902
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,0.97 [0.73-1.27],0.803643126229233
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,39,1.01 [0.97-1.06],0.495977318550228
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,0.99 [0.87-1.12],0.883861450016102
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRD1,Adhesion G-protein coupled receptor D1,Inverse variance weighted,36,1.04 [1.00-1.07],0.0338668722287791
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,16,1.05 [0.97-1.14],0.259630115176335
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAT,Tissue-type plasminogen activator,Inverse variance weighted,6,1.22 [0.97-1.53],0.0936876374784554
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSTN,Growth/differentiation factor 8,Inverse variance weighted,14,0.99 [0.90-1.08],0.786983650930407
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPC5,Glypican-5,Inverse variance weighted,53,1.02 [1.00-1.05],0.10095129502676
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VNN2,Vascular non-inflammatory molecule 2,Inverse variance weighted,40,1.02 [0.99-1.05],0.158836621230179
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,31,1.04 [0.99-1.10],0.126716898018123
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS3BP,Galectin-3-binding protein,Inverse variance weighted,30,1.00 [0.94-1.05],0.864893564962426
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH2,Cadherin-2,Inverse variance weighted,21,0.97 [0.86-1.09],0.565299494498839
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGF,Placenta growth factor,Inverse variance weighted,8,1.13 [0.97-1.31],0.118877202410634
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL1,Follistatin-related protein 1,Inverse variance weighted,15,1.08 [0.97-1.20],0.147636719221772
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS8,Prostasin,Inverse variance weighted,19,0.95 [0.83-1.07],0.376104717097286
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PI3,Elafin,Inverse variance weighted,20,0.96 [0.90-1.02],0.203336592588006
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF7,SLAM family member 7,Inverse variance weighted,40,1.01 [0.97-1.04],0.729956406422654
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST3,Cystatin-C,Inverse variance weighted,13,1.03 [0.97-1.10],0.351716392226155
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,13,0.97 [0.81-1.15],0.722179427018335
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN3,CCN family member 3,Inverse variance weighted,20,1.03 [0.97-1.10],0.288976205358098
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL22,C-C motif chemokine 22,Inverse variance weighted,13,1.01 [0.92-1.11],0.796764052769019
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDK,Midkine,Inverse variance weighted,19,1.08 [0.95-1.22],0.228153921080206
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,10,1.02 [0.87-1.20],0.781779449481059
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL9A1,Collagen alpha-1(IX) chain,Inverse variance weighted,14,1.03 [0.96-1.10],0.41071422620754
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,5,1.10 [0.90-1.34],0.368394430237425
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCA,Calcitonin,Inverse variance weighted,17,0.98 [0.86-1.11],0.735531517495801
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD83,CD83 antigen,Inverse variance weighted,19,0.96 [0.87-1.07],0.501195920573938
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,3,1.03 [0.81-1.31],0.834956182034045
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,22,0.96 [0.87-1.05],0.343481123067172
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,14,0.88 [0.78-1.00],0.0496860129970448
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,14,0.97 [0.90-1.04],0.366106945015559
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,Inverse variance weighted,28,1.04 [0.95-1.14],0.375007349443956
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,9,0.97 [0.88-1.06],0.445983413311135
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HYAL1,Hyaluronidase-1,Inverse variance weighted,23,1.08 [1.00-1.17],0.0467785551626566
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,Inverse variance weighted,6,0.99 [0.88-1.11],0.829107497926038
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OCLN,Occludin,Inverse variance weighted,3,1.18 [1.02-1.38],0.0284786757076141
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,9,1.01 [0.89-1.16],0.83418813074177
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,11,1.27 [1.06-1.51],0.0083088423120668
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,4,1.04 [0.87-1.23],0.674311519222737
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INHBB,Inhibin beta B chain,Inverse variance weighted,16,1.06 [0.94-1.19],0.376329592578075
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,30,0.97 [0.92-1.03],0.329002416038457
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,31,0.99 [0.96-1.02],0.457813397373568
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF3,Trefoil factor 3,Inverse variance weighted,10,1.07 [0.92-1.25],0.39512855627102
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,8,1.09 [0.97-1.23],0.157326804170442
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,34,0.97 [0.92-1.03],0.297061606863679
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,13,0.97 [0.94-1.00],0.0470457414436589
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAN,Brevican core protein,Inverse variance weighted,15,0.97 [0.88-1.07],0.484990003803395
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,23,0.96 [0.91-1.02],0.15152328804118
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK4,Kallikrein-4,Inverse variance weighted,20,0.99 [0.95-1.03],0.616019065214102
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY96,Lymphocyte antigen 96,Inverse variance weighted,19,0.99 [0.89-1.10],0.839631923209726
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL15,Interleukin-15,Inverse variance weighted,35,0.99 [0.92-1.06],0.730037530196577
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,4,0.99 [0.82-1.18],0.890018436094339
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,9,1.02 [0.91-1.15],0.738996980206285
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,18,0.97 [0.90-1.05],0.41722269258086
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL21,C-C motif chemokine 21,Inverse variance weighted,19,1.08 [0.97-1.21],0.168509275973288
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSLN,Mesothelin,Inverse variance weighted,36,1.03 [0.99-1.08],0.131499756330192
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,28,1.00 [0.97-1.03],0.925327399710475
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL32,Interleukin-32,Inverse variance weighted,20,0.95 [0.87-1.03],0.186926990877416
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL20,C-C motif chemokine 20,Inverse variance weighted,8,1.00 [0.87-1.15],0.978532320235046
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSL,Cathepsin L1,Inverse variance weighted,29,0.90 [0.84-0.97],0.0087195904705788
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,Inverse variance weighted,11,0.97 [0.93-1.02],0.298254274664761
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,15,0.94 [0.84-1.05],0.247137845166445
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,1.35 [0.70-2.60],0.368742648820698
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,1.15 [0.96-1.37],0.137924328870812
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAS6,Growth arrest-specific protein 6,Inverse variance weighted,28,1.00 [0.93-1.08],0.928972187774682
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,8,0.90 [0.76-1.06],0.201613391483886
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,0.95 [0.87-1.05],0.342199539512809
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,31,0.97 [0.89-1.06],0.500709342353361
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,18,1.01 [0.96-1.07],0.653712940305589
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEG1,Protein HEG homolog 1,Inverse variance weighted,18,1.02 [0.93-1.12],0.700171694474663
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AOC3,Membrane primary amine oxidase,Inverse variance weighted,35,0.97 [0.93-1.02],0.207372947754719
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,9,1.08 [0.99-1.17],0.0691349036360366
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP9,Matrix metalloproteinase-9,Inverse variance weighted,11,0.95 [0.84-1.07],0.391416720772451
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Inverse variance weighted,16,0.97 [0.91-1.03],0.313269358153146
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,15,1.01 [0.92-1.10],0.86770023285133
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALM2,Paralemmin-2,Inverse variance weighted,9,1.05 [0.97-1.14],0.238410915658897
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDN1,Endothelin-1,Inverse variance weighted,3,1.02 [0.93-1.12],0.648715103936031
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SULT2A1,Bile salt sulfotransferase,Inverse variance weighted,8,0.93 [0.84-1.02],0.107716908626024
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,29,0.98 [0.94-1.03],0.414246638094071
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP1,Insulin-like growth factor-binding protein 1,Wald ratio,1,1.07 [0.67-1.69],0.78174036284882
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,1.01 [0.87-1.18],0.885605725812421
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF8,SLAM family member 8,Inverse variance weighted,28,1.00 [0.98-1.02],0.804566917157873
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,24,1.06 [1.01-1.11],0.0247293645606975
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK10,Kallikrein-10,Inverse variance weighted,17,1.00 [0.95-1.06],0.996208302959404
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18BP,Interleukin-18-binding protein,Inverse variance weighted,13,0.93 [0.83-1.04],0.189725202575734
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,23,1.02 [0.98-1.05],0.35008825715643
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,19,1.01 [0.94-1.09],0.7150398102962
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADM,Pro-adrenomedullin,Inverse variance weighted,4,0.95 [0.84-1.08],0.453818004835056
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PVR,Poliovirus receptor,Inverse variance weighted,32,1.01 [0.97-1.04],0.691138833505612
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS9,Galectin-9,Inverse variance weighted,39,1.07 [1.03-1.12],0.0020543845284067
